Leukocyte aggregation

pathway activity — cross-omics
GO:0070486Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Leukocyte aggregation pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CYTIP, PTPN22, and CD226, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Leukocyte aggregation activity versus CYTIP in BRCA (Pearson r = 0.30).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACYTIP →+1.089+0.221<.001.00239
BRCAPTPN22 →+0.939+0.261<.001<.00139
HNSCCD226 →+0.640+0.195<.001<.00139
BRCATRGC2 →+1.491+0.249<.001<.00139
BRCANFAM1 →+0.828+0.202<.001.00139
BRCACSF2RB →+1.513+0.299<.001<.00138
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070486 vs CYTIP — BRCA

Per-sample scatter of Leukocyte aggregation activity vs CYTIP in BRCA.

Explore this scatter interactively →

Exploration